Company Analysis Exact Sciences Corporation
1. Summary
Advantages
- Price (54.01 $) is less than fair price (62.35 $)
- The stock's return over the last year (-9.82%) is higher than the sector average (-21.58%).
Disadvantages
- Dividends (0%) are below the sector average (0.5261%).
- Current debt level 46.47% has increased over 5 years from 26.96%.
- The company's current efficiency (ROE=-37.09%) is lower than the sector average (ROE=14.17%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Exact Sciences Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -1.6% | -21.2% | -0.3% |
| 90 days | 18.7% | -21.7% | 10% |
| 1 year | -9.8% | -21.6% | 9.7% |
EXAS vs Sector: Exact Sciences Corporation has outperformed the "Healthcare" sector by 11.77% over the past year.
EXAS vs Market: Exact Sciences Corporation has significantly underperformed the market by -19.55% over the past year.
Stable price: EXAS is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: EXAS with weekly volatility of -0.1888% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (54.01 $) is lower than the fair price (62.35 $).
Price not significantly lower than the fair price: The current price (54.01 $) is slightly lower than the fair price by 15.4%.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (63.23).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (89.86).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.31) is lower than that of the sector as a whole (18.83).
P/BV vs Market: The company's P/BV (4.31) is lower than that of the market as a whole (9.35).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (3.75) is lower than that of the sector as a whole (32.67).
P/S vs Market: The company's P/S indicator (3.75) is lower than that of the market as a whole (10.1).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-15.86) is lower than that of the sector as a whole (274.42).
EV/Ebitda vs Market: The company's EV/Ebitda (-15.86) is lower than that of the market as a whole (50.71).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 4.25% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.25%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-15.75%).
5.4. ROE
ROE vs Sector: The company's ROE (-37.09%) is lower than that of the sector as a whole (14.17%).
ROE vs Market: The company's ROE (-37.09%) is lower than that of the market as a whole (11.64%).
5.5. ROA
ROA vs Sector: The company's ROA (-16.6%) is lower than that of the sector as a whole (1.18%).
ROA vs Market: The company's ROA (-16.6%) is lower than that of the market as a whole (6.88%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-12.57%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (-12.57%) is lower than that of the market as a whole (11%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.5261%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
